cyclosporine has been researched along with Histiocytic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krilis, M; Miyakis, S | 1 |
| Cesano, A; Jeglum, KA; Santoli, D; Tran, T; Visonneau, S | 1 |
1 review(s) available for cyclosporine and Histiocytic Sarcoma
| Article | Year |
|---|---|
Cytophagic histiocytic panniculitis with haemophagocytosis in a patient with familial multiple lipomatosis and review of the literature.
Topics: Cyclosporine; Diagnosis, Differential; Family Health; Female; Genetic Predisposition to Disease; Histiocytic Sarcoma; Histiocytosis, Non-Langerhans-Cell; Humans; Lipomatosis, Multiple Symmetrical; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Panniculitis; Pedigree; Treatment Outcome | 2012 |
1 other study(ies) available for cyclosporine and Histiocytic Sarcoma
| Article | Year |
|---|---|
Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104.
Topics: Animals; Cyclosporine; Cytotoxicity, Immunologic; Dog Diseases; Dogs; Female; Histiocytic Sarcoma; Humans; Immunotherapy, Adoptive; Male; Neoplastic Cells, Circulating; Remission Induction; T-Lymphocytes, Cytotoxic | 1997 |